tiprankstipranks
Trending News
More News >
Nature's Sunshine Products (NATR)
NASDAQ:NATR
US Market

Nature's Sunshine Products (NATR) AI Stock Analysis

Compare
175 Followers

Top Page

NATR

Nature's Sunshine Products

(NASDAQ:NATR)

Select Model
Select Model
Select Model
Outperform 80 (OpenAI - 5.2)
Rating:80Outperform
Price Target:
$29.00
▲(16.79% Upside)
Nature's Sunshine Products receives a strong overall score driven by robust financial performance, positive technical indicators, and a highly favorable earnings call. The strategic appointment of a new CEO further supports growth prospects, although valuation metrics suggest moderate pricing relative to peers.
Positive Factors
Strong free cash flow generation
Sustained FCF growth at ~40% TTM supports reinvestment in product development, marketing and international expansion without relying on external financing. Strong cash conversion also provides a buffer for cyclical pressures and funds strategic initiatives over the next 2–6 months.
Very low leverage and strong liquidity
Minimal leverage and a strong equity base give the company durable financial flexibility to fund capex or M&A, withstand margin pressures, and avoid refinancing risk. This conservative capital structure supports stable operations and strategic options over multiple quarters.
High and improving gross margins
Elevated and rising gross margins reflect product quality, formulation control and pricing power, enabling stronger profitability even with modest top-line growth. Durable margin expansion enhances ability to fund SG&A and international expansion while protecting net earnings.
Negative Factors
Modest revenue growth rate
Revenue growth under 3% TTM suggests limited top-line momentum relative to peers and may constrain operating leverage. Without sustained acceleration, scaling investments and margin improvement could be harder to translate into meaningful EPS gains over the medium term.
Low net profit margin despite high gross margin
A low ~4.4% net margin despite >70% gross margins implies high SG&A or distributor costs. This limits retained earnings and sensitivity to cost inflation or tariff pressures, making long-term earnings vulnerability higher if operating expenses cannot be sustainably reduced.
Reliance on MLM distributor model
Dependence on an MLM channel creates structural growth constraints: recruitment-driven sales can be volatile, increase variable compensation costs, and attract regulatory scrutiny. Over months this can limit predictable revenue growth and raise compliance and retention expenses.

Nature's Sunshine Products (NATR) vs. SPDR S&P 500 ETF (SPY)

Nature's Sunshine Products Business Overview & Revenue Model

Company DescriptionNature's Sunshine Products, Inc., a natural health and wellness company, primarily manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. It offers general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision. The company also provides immunity, cardiovascular, and digestive products; and personal care products, such as oils and lotions, aloe vera gels, herbal shampoos, herbal skin treatment, toothpaste, and skin cleansers, as well as weight management products. It offers its products under the Nature's Sunshine and Synergy WorldWide brands through a sales force of independent consultants. The company was founded in 1972 and is headquartered in Lehi, Utah.
How the Company Makes MoneyNature's Sunshine Products generates revenue through several key streams, primarily by selling its health and wellness products directly to consumers and through a network of independent distributors. This multi-level marketing (MLM) model allows individuals to earn commissions not only on their sales but also on the sales made by their recruited distributors, fostering a community-driven sales strategy. The company also benefits from e-commerce sales through its website, providing a direct-to-consumer channel. Additionally, partnerships with various health and wellness retailers enhance its market reach. The company's ongoing investment in product innovation and marketing further drives sales growth and brand loyalty.

Nature's Sunshine Products Earnings Call Summary

Earnings Call Date:Nov 06, 2025
(Q3-2025)
|
% Change Since: |
Next Earnings Date:Mar 18, 2026
Earnings Call Sentiment Positive
The earnings call highlighted strong financial performance and growth across key regions, particularly in digital sales and the Asia Pacific market. The company demonstrated operational excellence with improved gross margins, a robust cash position, and raised full-year guidance. While there are concerns about tariff impacts and Q4 growth due to accelerated revenue recognition, these are relatively minor compared to the overall positive results.
Q3-2025 Updates
Positive Updates
Record-Breaking Quarterly Revenue
Net sales in the third quarter reached a quarterly record of $128.3 million, representing a 12% increase compared to $114.6 million in the year-ago quarter.
Significant Growth in Digital Sales
North America sales grew 7% year-over-year to $36.2 million with digital business showing a 52% year-over-year growth in Q3.
Strong Performance in Asia Pacific
Asia Pacific delivered 17% year-over-year net sales growth to $64.7 million, with notable growth in Japan (32%), China (36%), and Korea (12%) excluding foreign exchange impacts.
European Market Expansion
Europe's Q3 sales were up 13% to $22.1 million, driven by 10% growth in Central Europe and 14% growth in Eastern Europe.
Improved Gross Margin
Gross margin increased by 200 basis points to 73.3%, the highest in 15 quarters.
Adjusted EBITDA Growth
Adjusted EBITDA increased 42% to $15.2 million compared to $10.7 million in the year-ago quarter.
Strong Cash Position
Cash and cash equivalents were $95.6 million with zero debt, and net cash provided by operating activities was $25.4 million.
Raised Full-Year Guidance
The company raised its full-year 2025 net sales guidance to $476 million to $480 million, equating to a 5% to 6% year-over-year growth.
Negative Updates
Potential Impact of Tariffs
Anticipated small impact on gross margin due to tariffs, with margins likely to settle into the upper 72% range next quarter.
Q4 Revenue Timing and Comparisons
Approximately $2 million of revenue was accelerated from Q4 to Q3, and the company expects Q4 growth to be flat to slightly down in APAC due to difficult year-over-year comparisons.
Company Guidance
During the conference call, Nature's Sunshine raised their 2025 guidance based on a strong third quarter performance. Net sales reached a record $128.3 million, up 12% from the previous year, with a significant contribution from digital channels, which grew 52% year-over-year. The company also saw robust growth in the Asia Pacific region, with a 17% increase in net sales, and European sales up by 13%. As a result, Nature's Sunshine adjusted their full-year net sales outlook to between $476 million and $480 million, and increased their adjusted EBITDA guidance to a range of $47 million to $49 million, reflecting anticipated year-over-year growth of 16% to 21%. These results underscore the effectiveness of the company’s transformation initiatives and strategic investments.

Nature's Sunshine Products Financial Statement Overview

Summary
Nature's Sunshine Products exhibits solid financial health with consistent revenue growth, strong profitability margins, and effective cash flow management. The balance sheet is stable with low leverage, and the company is well-positioned to capitalize on future growth opportunities in the packaged foods industry.
Income Statement
75
Positive
Nature's Sunshine Products shows a steady revenue growth rate of 2.98% TTM, with a strong gross profit margin of 71.91%. The net profit margin has improved to 4.36% TTM, indicating enhanced profitability. However, the EBIT and EBITDA margins, while positive, suggest room for operational efficiency improvements.
Balance Sheet
80
Positive
The company maintains a low debt-to-equity ratio of 0.086 TTM, reflecting prudent financial management. Return on Equity (ROE) is at 9.42% TTM, showing a decent return for shareholders. The equity ratio is strong, indicating a solid capital structure with a good proportion of equity financing.
Cash Flow
78
Positive
Free cash flow growth is robust at 39.84% TTM, demonstrating strong cash generation capabilities. The operating cash flow to net income ratio is 0.32, indicating healthy cash flow relative to net income. The free cash flow to net income ratio of 0.88 suggests effective conversion of earnings into cash.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue474.54M454.36M445.32M421.91M444.08M385.20M
Gross Profit343.01M324.69M321.13M299.76M328.62M283.93M
EBITDA41.96M32.79M32.09M31.15M43.23M33.67M
Net Income15.09M7.70M15.08M-390.00K28.85M21.34M
Balance Sheet
Total Assets264.81M240.85M249.77M229.78M258.87M249.50M
Cash, Cash Equivalents and Short-Term Investments95.55M84.70M82.37M60.03M86.18M92.07M
Total Debt14.29M14.20M14.92M19.18M22.99M26.33M
Total Liabilities98.10M79.86M90.23M82.73M97.47M92.26M
Stockholders Equity160.50M155.31M154.06M142.91M158.20M155.39M
Cash Flow
Free Cash Flow31.27M14.33M30.75M-6.92M27.94M32.75M
Operating Cash Flow37.61M25.30M41.23M710.00K34.61M37.66M
Investing Cash Flow-6.34M-10.97M-10.48M-7.63M-6.61M-4.91M
Financing Cash Flow-15.82M-9.90M-7.96M-16.25M-31.72M3.88M

Nature's Sunshine Products Technical Analysis

Technical Analysis Sentiment
Positive
Last Price24.83
Price Trends
50DMA
22.05
Positive
100DMA
18.92
Positive
200DMA
16.82
Positive
Market Momentum
MACD
0.86
Negative
RSI
69.08
Neutral
STOCH
78.79
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For NATR, the sentiment is Positive. The current price of 24.83 is above the 20-day moving average (MA) of 22.95, above the 50-day MA of 22.05, and above the 200-day MA of 16.82, indicating a bullish trend. The MACD of 0.86 indicates Negative momentum. The RSI at 69.08 is Neutral, neither overbought nor oversold. The STOCH value of 78.79 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for NATR.

Nature's Sunshine Products Risk Analysis

Nature's Sunshine Products disclosed 26 risk factors in its most recent earnings report. Nature's Sunshine Products reported the most risks in the "Legal & Regulatory" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Nature's Sunshine Products Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
80
Outperform
$421.64M30.609.52%6.62%-7.85%
71
Outperform
$1.70B5.43-0.78%265.56%
66
Neutral
$73.54M7.5233.31%2.81%16.77%143.30%
62
Neutral
$20.33B14.63-3.31%3.23%1.93%-12.26%
58
Neutral
$554.27M-898.042.23%11.31%99.83%
56
Neutral
$390.66M24.363.20%5.88%-68.62%
48
Neutral
$24.95M-2.09-15.93%18.19%-35.22%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
NATR
Nature's Sunshine Products
24.83
10.92
78.50%
HLF
Herbalife
16.98
11.52
210.99%
NAII
Natural Alternatives International
4.09
-0.20
-4.66%
STKL
SunOpta
4.58
-2.75
-37.52%
USNA
USANA Health
21.68
-10.89
-33.44%
LFVN
LifeVantage
5.46
-15.36
-73.78%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Dec 09, 2025